Go to Page # Page of 17
loading

A New Medicine to Treat Inflammatory Diseases

 Thomas Jonassen, Jeppe Ovlesen
  12th-Apr-2019
Description: AP1189 is a new medicine to treat inflammatory diseases. AP1189 is developed as an add-on to MTX to reduce inflammation and support resolution.
Views: 2185
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: SynAct Pharma AB
 ‐ More of their Presentations
Contents:
AP1189 - A new medicine to treat inflammatory
diseases
Thomas Jonassen, CSO

Jeppe Øvlesen, CEO

Sedermeradagen Malmø 2018

IN A NUTSHELL
AP1189 – a melanocortin receptor agonist to reduce inflammation and “boost” healing
➔ First indication: active inflammatory joint diseases (rheumatoid and psoriatic arthritis)
➔ Opportunity: additional indications b ... See more

Recent Presentations

Yoojin Oh
20 September, 2019
...
19 September, 2019
...
18 September, 2019